Announced Wed, 2 Sept, 2026 · 23:29 IST
Independent Director regularized, WTD reappointed at Kwality Pharma
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹3397.60
prior close
₹3428.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-1.3-1.3-3.2-2.9+0.6+8.2+5.1+3.6+0.1+8.0+7.0——
Up moveDown movePending
AI summary
Kwality Pharmaceuticals shareholders at the 43rd AGM on August 31, 2026 approved two board changes. Mr. Swanith Kapoor, a legal professional holding a BBA LLB degree, was regularised as Non-Executive Independent Director for 5 years effective June 2, 2026 to June 1, 2031. Mr. Aditya Arora was reappointed as Whole Time Director for 5 years from September 30, 2026 to September 29, 2031, continuing his board role since October 2015 overseeing production, quality assurance and regulatory functions.
Likely market impact
Leadership continuity maintained. New independent director adds legal expertise to the board for governance.